Report Detail
Global (United States, European Union and China) LAMEA Oncology/Anti-cancer drugs Market Research Report 2019-2025
- RnM3390874 |
- 07 May, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
In 2019, the market size of LAMEA Oncology/Anti-cancer drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for LAMEA Oncology/Anti-cancer drugs.
This report studies the global market size of LAMEA Oncology/Anti-cancer drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the LAMEA Oncology/Anti-cancer drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Market Segment by Product Type
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
Market Segment by Application
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the LAMEA Oncology/Anti-cancer drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key LAMEA Oncology/Anti-cancer drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of LAMEA Oncology/Anti-cancer drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global LAMEA Oncology/Anti-cancer drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Blood Cancer
- 1.3.3 Breast Cancer
- 1.3.4 Gastrointestinal Cancer
- 1.3.5 Prostate Cancer
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global LAMEA Oncology/Anti-cancer drugs Market Share by Application (2019-2025)
- 1.4.2 Chemotherapy
- 1.4.3 Targeted Therapy
- 1.4.4 Immunotherapy (Biologic Therapy)
- 1.4.5 Hormonal Therapy
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global LAMEA Oncology/Anti-cancer drugs Market Size
- 2.1.1 Global LAMEA Oncology/Anti-cancer drugs Revenue 2014-2025
- 2.1.2 Global LAMEA Oncology/Anti-cancer drugs Sales 2014-2025
- 2.2 LAMEA Oncology/Anti-cancer drugs Growth Rate by Regions
- 2.2.1 Global LAMEA Oncology/Anti-cancer drugs Sales by Regions 2014-2019
- 2.2.2 Global LAMEA Oncology/Anti-cancer drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 LAMEA Oncology/Anti-cancer drugs Sales by Manufacturers
- 3.1.1 LAMEA Oncology/Anti-cancer drugs Sales by Manufacturers 2014-2019
- 3.1.2 LAMEA Oncology/Anti-cancer drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 LAMEA Oncology/Anti-cancer drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 LAMEA Oncology/Anti-cancer drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global LAMEA Oncology/Anti-cancer drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 LAMEA Oncology/Anti-cancer drugs Price by Manufacturers
- 3.4 Key Manufacturers LAMEA Oncology/Anti-cancer drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into LAMEA Oncology/Anti-cancer drugs Market
- 3.6 Key Manufacturers LAMEA Oncology/Anti-cancer drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Blood Cancer Sales and Revenue (2014-2019)
- 4.1.2 Breast Cancer Sales and Revenue (2014-2019)
- 4.1.3 Gastrointestinal Cancer Sales and Revenue (2014-2019)
- 4.1.4 Prostate Cancer Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global LAMEA Oncology/Anti-cancer drugs Sales Market Share by Type
- 4.3 Global LAMEA Oncology/Anti-cancer drugs Revenue Market Share by Type
- 4.4 LAMEA Oncology/Anti-cancer drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global LAMEA Oncology/Anti-cancer drugs Sales by Application
6 United States
- 6.1 United States LAMEA Oncology/Anti-cancer drugs Breakdown Data by Company
- 6.2 United States LAMEA Oncology/Anti-cancer drugs Breakdown Data by Type
- 6.3 United States LAMEA Oncology/Anti-cancer drugs Breakdown Data by Application
7 European Union
- 7.1 European Union LAMEA Oncology/Anti-cancer drugs Breakdown Data by Company
- 7.2 European Union LAMEA Oncology/Anti-cancer drugs Breakdown Data by Type
- 7.3 European Union LAMEA Oncology/Anti-cancer drugs Breakdown Data by Application
8 China
- 8.1 China LAMEA Oncology/Anti-cancer drugs Breakdown Data by Company
- 8.2 China LAMEA Oncology/Anti-cancer drugs Breakdown Data by Type
- 8.3 China LAMEA Oncology/Anti-cancer drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World LAMEA Oncology/Anti-cancer drugs Breakdown Data by Company
- 9.2 Rest of World LAMEA Oncology/Anti-cancer drugs Breakdown Data by Type
- 9.3 Rest of World LAMEA Oncology/Anti-cancer drugs Breakdown Data by Application
- 9.4 Rest of World LAMEA Oncology/Anti-cancer drugs Breakdown Data by Countries
- 9.4.1 Rest of World LAMEA Oncology/Anti-cancer drugs Sales by Countries
- 9.4.2 Rest of World LAMEA Oncology/Anti-cancer drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.1.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.2.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Celgene
- 10.3.1 Celgene Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.3.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.3.5 Celgene Recent Development
- 10.4 Amgen
- 10.4.1 Amgen Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.4.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.4.5 Amgen Recent Development
- 10.5 Johnson & Johnson
- 10.5.1 Johnson & Johnson Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.5.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.5.5 Johnson & Johnson Recent Development
- 10.6 GlaxoSmithKline
- 10.6.1 GlaxoSmithKline Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.6.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.6.5 GlaxoSmithKline Recent Development
- 10.7 Eli lilly & Co
- 10.7.1 Eli lilly & Co Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.7.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.7.5 Eli lilly & Co Recent Development
- 10.8 Pfizer
- 10.8.1 Pfizer Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.8.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.8.5 Pfizer Recent Development
- 10.9 Merck & Co.
- 10.9.1 Merck & Co. Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.9.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.9.5 Merck & Co. Recent Development
- 10.10 Sanofi
- 10.10.1 Sanofi Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of LAMEA Oncology/Anti-cancer drugs
- 10.10.4 LAMEA Oncology/Anti-cancer drugs Product Introduction
- 10.10.5 Sanofi Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 LAMEA Oncology/Anti-cancer drugs Sales Channels
- 11.2.2 LAMEA Oncology/Anti-cancer drugs Distributors
- 11.3 LAMEA Oncology/Anti-cancer drugs Customers
12 Market Forecast
- 12.1 Global LAMEA Oncology/Anti-cancer drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global LAMEA Oncology/Anti-cancer drugs Sales Forecast by Type
- 12.3 Global LAMEA Oncology/Anti-cancer drugs Sales Forecast by Application
- 12.4 LAMEA Oncology/Anti-cancer drugs Forecast by Regions
- 12.4.1 Global LAMEA Oncology/Anti-cancer drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global LAMEA Oncology/Anti-cancer drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on LAMEA Oncology/Anti-cancer drugs . Industry analysis & Market Report on LAMEA Oncology/Anti-cancer drugs is a syndicated market report, published as Global (United States, European Union and China) LAMEA Oncology/Anti-cancer drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of LAMEA Oncology/Anti-cancer drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
